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Introduction
In the year 1856, the German scientist Freidrich Ludwig 
????????? ?????????? ????? ???? ????? ????? ???? ????? ?????????
case of the Long QT syndrome (LQTS).  He recorded a case in 
which a deaf female student died suddenly during a moment of 
emotional stress. There had been two other children in her fam-
ily who had died previously under similar circumstances.  Since 
a diagnosis of LQTS requires an electrocardiogram, and at that 
time the ECG had not yet been invented, (Rivera-Ruiz, 1927) 
it is not known for certain that these cases were an example 
of LQTS (Vincent, 2002).  Over a hundred years later, a study 
was performed on a family of 10 children. Four of the children 
had profound deafness and would often faint during moments 
of emotional or physical stress (Jervell, Lange-Neilson, 1957). 
Later, a similar familial tendency to faint during stress was ob-
served in case studies (Ward, 1964). A prolonged QT interval 
was observed in the ECGs of subjects. At that time, two familial 
heart diseases known collectively as Long QT Syndrome were 
????????????????????????????
The advent of molecular and genetic science has revolu-
tionized the medical world’s approach to this disease, as it has 
done for that of many others. Molecular studies have divided 
the cases of LQTS, which seemed in the past like one basic 
condition, into larger categories differentiated based upon mo-
lecular mechanism. Genetic differences were discovered be-
tween these types in the lab, and since genetic testing became 
available to the public in 2004, 15 categories including over 
1500 different mutations have been found to be the underlying 
cause of a prolongation of the QT interval. This study focus-
es on the three categories which make up the overwhelming 
majority of cases. In some cases, certain genetic origins and 
molecular mechanisms have been linked to certain phenotypic 
characteristics, and some believe that genetic diagnosis may 
aid in recommendations and treatment for LQTS patients. 
This study aims to give a full description of the physiological 
and molecular mechanisms of LQTS based upon the latest re-
search, and analyze the contribution of genetic research to the 
understanding and treatment of the disease. Most importantly, 
the primary objective of this study is to answer the question: 
Should genetic testing be universally recommended to LQTS 
patients and their relatives?
Methods
The Touro library system was an invaluable source of recent, 
high-quality academic papers. In addition, the National Institutes 
of Health and NCBI provided excellent references to PubMed 
articles which provided useful information. The author sought 
out independent studies and other primary sources to pro-
vide up-to-date reports of developments in the molecular and 
genetic understanding of the disease. Studies regarding recent 
????????? ??? ????????????? ??????????? ???? ???????? ?????????
medical surveys are considered in determining when genetic 
testing is indicated.
Discussion 
Physiology of LQTS
The QT interval indicates the length of time from the begin-
ning of the depolarization of the ventricles to the end of their 
repolarization. A prolonged QT interval will mean that the 
ventricles are taking too long to repolarize. This usually does 
not interfere with cardiac function, but occasionally can cause 
????????????????? ???????????? ?????????????????????????????????
??? ???????????? ???????????? ?????? ??? ???????? ?????? ??? ?? ???-
longed QT interval is the result of Early Afterdepolarizations 
(EADs). The plateau curve caused by the delay in repolariza-
tion can cause some of the heart’s cells to begin depolarizing 
while others are in the process of repolarizing. This can cause 
heterogeneous activity in the heart tissue, especially the ven-
tricles, with some regions contracting and others relaxing. The 
?????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????
(January, et. al. 2000).
Clinical Manifestation
Normally, depolarization and excitation of the cells of the heart 
???? ?????????? ?? ?????? ???? ??????????? ??????????? ???????? ??????
These are usually Sodium and Calcium ions. However, the repo-
????????????????????????????????????????????????????????????????????
back out; it is an outward current of positively charged Potassium 
?????????????????? ??????????????????? ????????????????????? ??-
????????? ??? ?????????? ???? ??????? ??????? ???? ???? ????? ??????? ???
repolarize. In all forms of LQTS, the symptoms are caused by 
a surplus of positive charges remaining within the cell. When 
some channels malfunction, the extra positive charge is caused 
Abstract
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by reduced outward Potassium current. When other channels 
malfunction, the extra positive charge is caused by increased or 
unchecked inward Sodium current. In either case early afterde-
polarizations can result, meaning that depolarization may still be 
going on after the effects of repolarization have subsided. This can 
cause what is called a U wave (Roden, et. al. 1996). This U wave, 
however, is not a homogenous contraction of the heart. Some of 
the cells will show this depolarization, and others will not. If this 
EAD is still going on when the next beat occurs, it can cause the 
heart to contract in an uneven way (Antzelevitch, Sicouri, 1994). 
This leads to a characteristic ECG graph known as Torsades de 
Pointes.  This is French for “Twisting of the Points,” and is named 
for the peculiar way the wave form seems to twist around the 
isoelectric line (El-Sherif, et. al. 1996).
??????????????????????????????????????????????????????????????
volume of blood to support brain function. After some time 
with this abnormal ECG morphology, the patient will faint. Most 
of the time, the heart will overcome the Torsades and regain a 
normal heartbeat. At other times, the heart will not be able to 
“snap out of it” and the rhythm will deteriorate to ventricular 
??????????????????????????????? ????????????????????????? ???????
Unfortunately, this situation leads to death within minutes.
A patient who presents with Torsades is considered a medical 
???????????????????????????????????????????????????????????????
result. However, the situation rights itself in the vast majority of 
????????????????????????????????????????? ????????????????????-
mary course of action since it can cause recurrent arrhythmias. 
One of the major aspects of treatment is preventing the patient 
from returning to a state of Torsades; whatever caused it the 
??????? ???????????????????????? ?????????????????????????????????
or mitigate the effects of any drugs which may have caused the 
Torsades. It is also advisable to take measures to suppress EADs, 
among other things. Magnesium is effective at suppressing EADs 
(Viskin, 1999).
Since the danger resulting from a prolonged QT interval de-
pends not only on the actual length of the interval but also the 
way it interacts with the surrounding segments of the ECG wave, 
it is important to have a method with which to accurately mea-
????? ????????????? ???????????????????????????????????????????????
To this end, the concept of QTc was developed, in which the 
actual length of the QT interval is mathematically corrected to 
take heart rate into account (Bazett, 1920). Since that time, many 
other methods have been proposed, and the medical community 
is currently in debate over which is most useful and accurate.
Molecular Mechanisms
To understand the cellular and molecular mechanics of Long 
QT Syndrome, we must understand the process of the ac-
tion potential itself. At rest, nerve cells have a higher level of 
positive charge outside the cell than they do inside.  When a 
nerve cell is stimulated, the chemical or electrical impulse it 
receives activates voltage- or ligand-gated Sodium channels. 
???????????????????????????????????????????????????????????? ?????
??????????????????????????????????????????????????????????????-
???????????????????????????????????????????????????????????????
of Potassium ions and returning the cell to its resting state with 
more positive charge on the outside. Many different types of 
channels are involved in these processes. Cardiac muscle cells 
are unusual in the sense that they act to carry an action poten-
????? ?????????????? ??????????? ???????????? ???? ?????????????????
upon a similar set of ion channels (Sanguinetti, Jurkiewicz, 1990). 
We will delve deeper into this process shortly.
Some years ago, a groundbreaking study uncovered infor-
mation about the process of repolarization in cardiac tissue. 
The goal was to understand electrophysiological differences 
between different areas of the heart.  Microelectrodes were 
used to measure delays in repolarization found in certain canine 
heart cells, known as M cells. These cells, which had been previ-
ously found to show markedly longer repolarization times, are 
found in the deep sub-pericardial and mid-myocardial regions. 
The researchers measured the durations of their action poten-
tials to have a mean of 358 ms, as opposed to 282 ms or 287 ms 
found in other regions of cardiac muscle. Upon further exam-
ination of the M cells, it was shown that they show differences 
in IK when compared to other cells. IK means Potassium ion 
current, which is the current responsible for the repolarization 
that ends every action potential. There are two distinct currents 
found in cardiac cells, the IKr, or rapid-activating current, and 
the IKs, or slow-activating current. These currents are mediated 
by two separate transmembrane voltage-gated protein channels. 
The M cells have smaller IKs (Slow-acting Potassium current) 
than the other cells, while IKr (Rapid-acting Potassium current) 
is generally the same. (Of course, the mechanism for the rate 
of an action potential has many factors, and depends upon the 
??????? ????????? ??????? ???????? ???? ??????? ????????? ???????
Potassium pump inward current, Sodium-Calcium inward cur-
rent, and others.) (Sanguinetti, Jurkiewicz, 1990). The IKs in the 
M cells was measured using a selective IKr blocker, E-4031. The 
Potassium current was measured in the cells with E-4031 and 
in the cells without E-4031. The difference between the two 
measurements was the IK due to IKr, and the common portion 
was the IK due to IKs. It was found that the IKr in different cell 
types was essentially the same, and reduced IKs current was 
responsible for the delayed repolarization in the M cells. It was 
discovered in this study that IKr differs from IKs in its kinetics of 
activation, more negative threshold for activation, and different 
protein structure suggested by its selective blockage by meth-
ane sulfonamide class III agents like E-4031. However, studies of 
M cells demonstrated that delayed IKs can play a principle role 
in delayed repolarization. The researchers predicted that the M 
cells may be found to be the culprits of diseases such as LQTS 
(Liu, Antzelevitch, 1995). 
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Later the same year, it was shown that the plateau portion of 
repolarization is accomplished principally by the IKs protein. It 
was also discovered that in the heart in general, blocking either 
IKr or IKs can prolong duration of the action potential by the 
same degree.  This means that either protein can be a target for 
antiarrhythmic drugs for tachycardia. By the same token, either 
protein could also be the culprit of an arrhythmia with extend-
ed action potentials, such as LQTS (Zeng, et. al. 1995.) As we 
????? ???? ?????? ???????? ???????? ????? ????????? ????? ????? ????
result from mutations in the genes which code for either of the 
proteins, and others as well.
Genetic Variation
It has been known for many years that not all cases of LQTS 
have the same symptoms. For example, some cases of LQTS 
????????????????????????????????????????????????????????????????
Other cases are set off especially by exercise, whereas some 
?????? ????? ??? ?????? ???????? ???????????? ??????? ??? ?????? ???
was established that in these cases it was not the stress or 
exercise of swimming which caused the ill effects, but rather the 
actual immersion of the face in cold water (Mayumi, et.al. 1995).
Genetic research has since shown that mutations in several 
genes, coding for several proteins, can cause LQTS. Different 
types of the disease have been linked to different genes, and 
over 1500 different novel mutations have thus far been discov-
ered on 15 different genes which code for 15 different proteins. 
One such gene is the KCNQ1 gene. This gene on chromosome 
11 codes for the alpha subunit of the voltage-gated Potassium 
channel. It has six transmembrane domains. Even though there 
is ion pore function for this protein alone, some of the func-
tioning of the channel requires it to be co-assembled with the 
beta subunit. This subunit is called KCNE1.  The two subunits 
together account for the cardiac IKs. Mutations in different seg-
ments of this protein channel cause varying degrees and kinds 
of diseases. The S4 domain contains a voltage sensor, and loss-
of function mutations in this area can cause LQTS. In addition, 
????????????????????????????????????????????????????????????????
its shape is altered, severely affect the functioning of the IKs 
current. In this segment, certain mutations cause more loss of 
function than others. For example, an I313K mutation in the se-
???????????????????????????????????????????????????????????????
including syncope and risk of death, whereas an I313M mutation 
will prolong the QT interval, but the patient will be otherwise 
asymptomatic. All KCNQ1 and KCNE1 mutations are included 
in the category LQT1 (Ikrar, et. al. 2008).
LQT2 is a result of a loss of function in the HERG channel. 
HERG stands for Human Ether a go go related gene, so named 
???????? ????? ???????????????? ??? ???????????? ??? ??????????????????
them to “dance” when exposed to ether. More than 80 mutations 
were known in this gene in 2000, and many more are known 
today. HERG is a gene located on chromosome 7 that codes for 
the pore-forming subunit for the IKr channel. There are several 
mechanisms by which HERG mutations cause reduced IKr. One 
of them is that a certain degree of codominance exists in het-
erozygous individuals with certain mutations. The protein which 
comprises the HERG channel is actually a tetrameric structure 
formed by the co-assembly of four copies of the HERG gene 
product. Depending on how the subunits combine, the mutant 
gene products might be excluded from the ion pores, causing 
a 50% reduction in pore function. On the other hand, the mu-
tants might be included in some of the complete proteins, causing 
more than 50% to be defective. Other mutations in the HERG 
gene are truly dominant, and produce channels which activate 
at voltages which are more negative than usual.  One mutation, 
N629D, was found to make the pore channel nonselective and 
allow ions other than K+ to pass through. Interestingly, many 
mutations in the HERG protein affect not the actual functioning 
????????????????????????????????????? ?????????????????????????????????
packaged and transported to the plasma membrane.  In these 
cases, the mutant proteins are marked as abnormal by the cell’s 
quality control systems and are kept in the endoplasmic reticu-
lum and degraded. In these scenarios, applying E-4031 to affected 
??????????????????????????????????????????????????????????????????
membrane, and the drug could later be washed off. Applying this 
method in vivo is still an area of study for these particular mutant 
???????? ???????????????????????????????????????????????? ???????
form may be increasing serum K+ concentration, since HERG 
current is highly sensitive to extracellular K+ concentration. 
(January, et. al. 2000) 
??????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????
that certain mutations cause misfolding of the protein, and this 
is what prevents it from leaving the endoplasmic reticulum. This 
was discovered by causing chemical unfolding of several differ-
ent mutant forms and measuring the difference between the 
stabilities of each mutant’s folding. It was found that there was 
a direct correlation between the conformational stability of the 
???????? ???? ???? ??????? ??? ??????????? ?????????? ????????? ???? ????
2012).
LQT3 is has a very different molecular basis from that of both 
???????????????????????? ???? ??????????????????????????
are caused by malfunction of Potassium channels. These chan-
????? ????????? ??? ??????? ????????????? ????????? ???????????????
repolarization of the heart’s muscle cells. These mutations are 
examples of what is known as “loss of function” mutations. In 
other words, the protein coded for by the gene does not work 
as well with the mutation as it does in the wild type. LQT3, 
however, is a “gain of function” mutation. It causes the Sodium 
channel pores to become more effective than in the wild type. 
This means that the depolarization process lasts longer, thereby 
slowing repolarization and extending the QT interval (Mazzanti, 
et. al. 2016).
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????????????????????????????????? ????????
Phenotypic differences have been found between LQT1 and 
LQT2. Heterogeneity has been noticed among LQTS patients 
regarding the effect that exercise has in precipitating Torsades 
??? ???????? ???? ???????????? ????????????? ??? ???? ??????????? ?????
patients matched for age and gender showed differing QT ad-
aptation patterns during exercise. Patients with LQT1 showed 
a steady QTc prolongation, even at higher heart rates. Since 
each heart beat occurs at a faster rate, and the QT prolonga-
tion remains the same, it is more likely that the repolarization 
process will interfere with the following QRS complex, bringing 
??????????????? ??? ???????? ???? ???????????? ????????????? ????????
syncope or death. In LQT2, however, the QT interval prolon-
gation is actually reduced as the heart rate increases, meaning 
that the QT interval occupies the same proportion of the total 
ECG sequence that it does at lower heart rates, such as during 
rest. Therefore there is no greater risk of syncope in LQT2 
during exercise than at any other time. This is consistent with 
the molecular and genotypic understanding of the differences 
between these two disease types. Exercise creates an increase 
in sympathetic activity, i.e. the heart is being driven not only 
by its internal pacemaker, but also by hormonal and systemic 
nervous impulses and stimulants, such as epinephrine and other 
adrenergic agents. In this situation, the predominant current for 
the increase in the rate of repolarization has been proven to be 
the IKs current, precisely that one which is affected by LQT1. 
Therefore, it is understandable that LQT1 patients will be more 
susceptible to syncope brought on by exercise-related stress. 
These differences are generalizations; actual recommendations 
to patients still must be based upon observation and testing 
under different types of stress (Sy, et. al. 2010).
In addition, many symptoms have been found to be associat-
ed with different forms of LQTS. As stated, LQT1 is associated 
with syncope brought on by exercise, with swimming being a 
particular stimulus in certain cases. LQT2 is associated with 
cardiac events connected with mental stress such as fear or 
anger. LQT2 patients also faint when they hear sudden noises 
such as alarm clocks and phones.  LQT3 seems to be associated 
with attacks which come while a person is resting or sleeping. 
Knowledge of the genetic basis of the disease can thus be helpful 
in advising the patient which activities to avoid. However, even 
??????? ?????????????? ?????? ??? ?? ??????????? ???????????? ??? ??????
properties with these forms of the disease, a genetic diagnosis 
?????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????
general trend. Therefore, although genetic testing can be helpful 
in planning an avoidance or treatment plan, clinical manifestation 
is the ultimate deciding factor (Mangset, Hoffman, 2014). 
???????? ????????????? ?????????? ????? ????? ????????? ????
LQTS. Beta Blockers are effective for LQT1 and LQT2, whereas 
they can have negative effects in the case of LQT3. Potassium 
supplements also are suggested for LQT2, since an elevated 
blood potassium level has been shown to enhance the activity of 
the HERG channels. Mexiletine, a methane sulfonamide Sodium 
channel blocker, may be effective for LQT3, as described before. 
Although some of these have shown promise, comprehensive 
???????????????????????????????????????????????????????????????-
tablished (Viskin, 1999.) Recent studies have shown Mexiletine 
to be effective at reducing the QTc of more than two thirds of 
patients with LQT3. These studies had certain limitations, how-
?????? ????????????? ???????????????? ?????????????????????? ?????
??????????????????????????????????????????????
Implications of Genetic Testing
Since 2004, genetic testing has been made available on symp-
tomatic people to discover what the genetic source of their 
syncopal episodes may be. However, in many cases there is a 
dilemma for the patient. Most cases of LQTS do not require 
genetic testing for diagnoses, and if pathology is suspected in a 
newborn based on heredity, risk of serious effects can usually be 
effectively determined by ECG. In addition, even if the genetic 
testing comes up clear, preventive measures will still be taken 
for anyone whose QTc is over the limit of .45 ms. Therefore, 
???? ??? ???? ????????????? ???? ???????? ???????? ??? ???? ?????????-
?????? ???? ??????? ???? ???????????? ????? ????????????? ?????????????
??? ?????????????? ???????????????? ????????????? ????????????????
require a genotypic diagnosis are still not available to the public. 
Those therapies and recommendations which are available can 
be safely used without genetic testing. This creates a dilemma 
for many patients and their relatives. On the one hand, there 
is the patient’s right to know. A clear, empirical knowledge of 
the source of their disease helps some patients adjust and cope 
psychologically. On the other hand, who would want to know 
for certain that they carry a gene which may or may not have 
deleterious effects on their children? Since there are effective 
?????????? ????????? ???? ????? ?????????? ???? ??? ?? ???????????
source of fear and anxiety as well as causing moral dilemmas, 
many people are uncomfortable going for testing. Sensitivity to 
this discomfort has been termed by some as “the patient’s right 
not to know.” This consideration is rarely addressed by health 
care providers, and the National Society of Genetic Counselors 
is making an effort to educate providers about the psychological 
impact of genetic testing (Mangsett, Hoffman, 2014).
 A longitudinal study was done to observe the long-term ef-
fects of congenital LQTS. Individuals from 328 families with mul-
tiple cases of LQTS were observed over the course of several 
years.  The probands had usually fainted at some time during 
their childhood years, with an episode of fainting or death oc-
curring in 50% of them by age 12.  The majority were women, 
showing that the effects of the gene are more serious in females. 
The yearly rate of fainting spells till age 50 was 5.0% per year for 
those enrolled in the study, and the rate of death was .9%. This 
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was higher not only than the rates in unaffected family members, 
but also higher than the rates in affected family members. This 
shows that LQTS genes can have a variable level of expression 
even among affected people (Moss, et. al. 1996). Since the dis-
ease can have varying levels of effect even among those who are 
stricken by it, it may be true that testing of all family members 
can help in discovering mildly affected people.
More recently, however, a survey was taken to determine the 
effects of genetic abnormalities on people who were otherwise 
clinically normal in terms of ECG and symptoms. Interestingly, 
no ill effects were found to be associated with genetic defects 
alone, even in situations where those same genetic defects pro-
?????? ??????????????????? ??????????????????? ????? ???????? ?????
this might be affected by the fact that genetically positive pa-
tients tend to take care to avoid activities which bring on syn-
copal episodes. This information was not part of the study how-
ever, and it is therefore unclear whether clinically normal but 
genetically abnormal individuals need to take any action at all 
to protect themselves from syncope or death (Lampert, 2015).
One other argument has been made in favor of genetic testing 
of family members of affected individuals. Some drugs which are 
administered by psychiatrists to relieve psychological symptoms 
either function directly through changing the electrophysiolog-
ical workings of the heart, or have side effects which can affect 
or alter the action potential of the heart cells. It is suspected 
that an increased rate of sudden death among psychiatric pa-
tients may be caused by underlying QT interval abnormalities 
which may, when augmented by the effects of the drugs, come to 
have deadly effects upon the heart’s rhythm (Sayako, et.al. 2014.) 
However, the effects were only observed in a small percentage 
of the psychiatric population.
???????????????????????????????????????????????????????????-
ly pathogenic. Individuals who carry these variants are advised 
to take beta blockers as a prophylactic measure. Although these 
????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????
risk in unaffected people, and the testing of relatives is not uni-
versally required (Vincent, 2001).
Conclusions
The Long QT Syndrome is a great example of how a little infor-
mation can be a dangerous thing. This is an area in which there 
has been a recent surge in pure information: exact mutation types, 
statistics, symptoms, etc. However, the tying together and under-
standing of this information is lagging far behind its production, 
and that which exists is ambivalent and confusing. Since people 
rely on their healthcare providers not only for information, but 
??????????????????????????????????????????????????????????????????-
vider to respond appropriately to questions about this disease. 
One patient commented that he gets different recommendations 
from the same doctor on different occasions. In these situations 
?????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????-
cance of genetic results, and possibly nobody in the world knows 
(Mangsett, Hoffman, 2014).
??????????????????????????????????????????????????????????????-
ing of LQTS. However, both methods of interpreting the genetic 
????? ???? ???? ??????????? ??????????? ??? ????????? ??? ???? ????????
types have not yet been developed in a way which provides in-
???????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????? ???? ?????
????????????????????????????????????????????????????????????????????????
submit to genetic testing, since research has observed emotion-
??????????????????????????????????????????? ????????????????? ????????
????????? ?? ???????? ?????????????????? ???? ????????? ???? ?????-
mendations and, to some degree, the treatment that a patient will 
be provided with. In addition, since treatment is recommended 
for some variants even in the absence of ECG symptoms, relatives 
of individuals with those variants have more reason to submit 
for genetic testing. A physician and genetic counselor should 
??????????????????????????????????????????????????????????????????????
the patient or relative, and the patient or relative should decide 
whether or not to submit to testing. In the coming years, the ap-
??????????????????????????????????????????????????????????????
testing more important for affected individuals.
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